 | | | | - Among its peer group, it has low Volatility, high Earning Rate | | - All related stocks also decline. Medical Supplies industry -2.69% | | - Target price KRW 100,000, has 59% disparate to increase compared with stock price. | | - Individuals and Foreigners sell, Institutions buy | | - Turnover Rate and Price Range both proper | | - Institution 32.76%, Foreigners 16.77% |
|
|
On Oct. 25, LG Life Sciences (068870) declined 1.57% to 62,600 won (US$ 55.07). It had declined 1.88% through the past month. Standard deviation, which indicates risk, records 2.2% on the same period over one month.
Compared with its close competitors within the same industry, KOSPI, the investment return of LG Life Sciences was the most satisfactory among its peer group and its volatility for 1 month was also proper. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -0.8%. Though the volatility was high, the return-on-risk record high value compared with its peer group. Moreover, compared with the KOSPI industry, the return-on-risk is much better than the industrial mean, -1.5, and thus the industrial comparison performance was good.
| Close Competitors | Earning rate (%) | STD (1Mo) | Return on
Risk (1Mo) | | 1 Mo | 3 Mo | 6 Mo | | JEIL PHARM(002620) | -31.7% | 0.9% | -4.6% | 3.8% | -8.3 | | JW PHARMA(001060) | -28.3% | 0.2% | 49.1% | 3.7% | -7.6 | | LG Life Sciences(068870) | -1.9% | -14.4% | -10.7% | 2.2% | -0.8 | | BUKWANG PHARM(003000) | -11.4% | -18.1% | -10.8% | 2.1% | -5.4 | | GC Corp(006280) | -20.0% | -18.9% | -16.6% | 1.9% | -10.5 | | | | Medical Supplies | -20.9% | -17.7% | -22.5% | 1.7% | -12.2 | | KOSPI | -0.9% | -0.3% | 1.1% | 0.6% | -1.5 |
|
Target price KRW 100,000, has 59% disparate to increase compared with stock price.
Per analysts' expectations during the recent month, the average target price of LG Life Sciences is 100,000. The stock price is 62,600 won, so there is 37,400 (59%) disparate in order to be able to increase.
P/E ratio and P/B ratio
| Close Compatitors | ROE | PER | PBR | Basic Date | | LG Life Sciences(068870) | 12.7 | 30.0 | 3.8 | June 2016 | | JW PHARMA(001060) | -6.0 | - | 5.2 | June 2016 | | BUKWANG PHARM(003000) | 15.3 | 30.7 | 4.7 | June 2016 | | GC Corp(006280) | 7.3 | 23.3 | 1.7 | June 2016 | | JEIL PHARM(002620) | 4.1 | 108.9 | 4.4 | June 2016 |
Individuals and Foreigners sell, Institutions buy
While institutions have been buying LG Life Sciences during the past 7 trading days, foreigners have been selling during the past 2 trading days. As a shareholding sum by investor group for the past 4 weeks, institutions have bought 277,693 shares with trending trade. However, during the same period, foreigners have sold 136,379 shares with maintenance of a selling position and individuals have sold 141,314 shares as they turn toward a selling stance.
| Cumulated shareholdings per investor group (1Mo) | | Total shareholdings per investor group |  | |  |
| * Other Investor groups, included as "other corporations", are considered as "Individuals". |
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp. |
![[Weekender] How DDP emerged as an icon of Seoul](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=645&simg=/content/image/2024/04/25/20240425050915_0.jpg&u=)
